You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • FRI0325 The Use of Intravenous Expanded Allogeneic Adipose-Derived Mesenchymal Stem Cells in Refractory Rheumatoid Arthritis Patients. A Phase Ib/Iia Study

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - other biologic treatment
FRI0325 The Use of Intravenous Expanded Allogeneic Adipose-Derived Mesenchymal Stem Cells in Refractory Rheumatoid Arthritis Patients. A Phase Ib/Iia Study

 

Online download statistics by month:

Online download statistics by month: June 2014 to February 2024

AbstractFullPdf
Jun 2014500
Jul 2014700
Aug 2014101
Sep 2014900
Oct 2014204
Nov 20141600
Dec 2014501
Feb 2015600
Mar 2015701
Apr 2015100
May 2015201
Jun 2015401
Jul 2015100
Aug 2015900
Sep 20151101
Oct 2015400
Nov 20151600
Dec 20151100
Jan 20161200
Feb 2016800
Mar 2016700
Apr 2016500
May 20161000
Jun 2016701
Jul 20161200
Aug 2016900
Sep 2016500
Oct 2016400
Nov 2016803
Dec 20161401
Jan 2017300
Feb 2017201
Mar 20171401
Apr 20171001
May 2017500
Jun 2017800
Jul 2017800
Aug 20171200
Sep 2017800
Oct 20171200
Nov 20172200
Dec 20172800
Jan 20181000
Feb 20182001
Mar 20183400
Apr 20182400
May 20188201
Jun 20181400
Jul 20181400
Aug 20181600
Sep 20181401
Oct 2018600
Nov 20181200
Dec 20181200
Jan 2019800
Feb 20191000
Mar 2019800
Apr 20191201
May 2019400
Jun 2019401
Jul 2019600
Aug 20191401
Sep 2019401
Nov 20192200
Dec 2019600
Jan 2020400
Feb 2020800
Mar 20202402
Apr 20201000
May 2020400
Jun 2020200
Jul 2020200
Sep 20201201
Oct 20201001
Nov 2020400
Dec 2020200
Jan 2021200
Feb 2021400
Oct 2021200
Dec 2021600
Jan 2022600
Feb 2022200
Mar 2022800
May 2022400
Jun 2022500
Jul 20221200
Aug 20221401
Sep 2022200
Oct 20221802
Nov 2022700
Dec 2022600
Feb 2023400
Mar 2023200
May 2023200
Jun 2023600
Jul 2023600
Aug 2023800
Sep 2023400
Oct 2023800
Nov 2023800
Dec 20232400
Feb 2024200
Total960032